Senores Pharmaceuticals relieves Company Secretary from duties

1 min read     Updated on 11 Jun 2026, 12:42 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Senores Pharmaceuticals Limited relieved Company Secretary Vinay Kumar Mishra from his duties effective the close of business hours on June 10, 2026, based on his earlier resignation intimation dated May 14, 2026. In compliance with Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company authorized Managing Director Mr. Swapnil Jatinbhai Shah and Whole Time Director and Chief Financial Officer Mr. Deval Rajnikant Shah to determine the materiality of events and information for disclosures to the stock exchanges. The company confirmed that all requisite information, including the copy of the resignation letter, was previously submitted to the exchanges as per the relevant SEBI circular.

powered bylight_fuzz_icon
42646336

*this image is generated using AI for illustrative purposes only.

Senores Pharmaceuticals Limited relieved Company Secretary Vinay Kumar Mishra from his duties effective the close of business hours on June 10, 2026. The company informed the stock exchanges that the relief follows his earlier resignation intimation dated May 14, 2026.

In accordance with Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has designated specific Key Managerial Personnel (KMP) to determine the materiality of events and information for disclosures to the exchanges.

The authorized personnel include Managing Director Mr. Swapnil Jatinbhai Shah and Whole Time Director and Chief Financial Officer Mr. Deval Rajnikant Shah. The contact details for the Managing Director have been provided to facilitate necessary communications.

The company confirmed that the requisite information, including the copy of the resignation letter, was previously submitted to the exchanges as per SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Authorized Key Managerial Personnel

Sr. No. Name Designation Contact Details
1. Mr. Swapnil Jatinbhai Shah Managing Director Registered Office: 1101 to 1103, 11th floor, South Tower, ONE 42, opposite Jayantilal Park, Ambali Bopal Road, Ahmedabad, Gujarat, India, 380054
Tel.: +91-79-29999857
E-mail: cs@senorespharma.com
2. Mr. Deval Rajnikant Shah Whole Time Director and Chief Financial Officer

Historical Stock Returns for Senores Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+11.14%+23.52%+34.68%+68.93%+137.96%+131.58%

Who will be appointed as the new Company Secretary to fill the vacancy left by Vinay Kumar Mishra?

What impact will this leadership change have on Senores Pharmaceuticals' upcoming regulatory compliance and disclosure timelines?

Are there any strategic shifts or internal reorganizations expected following the resignation of the Company Secretary?

Senores Pharmaceuticals
View Company Insights
View All News
like18
dislike

Senores Pharmaceuticals to hold investor conference on June 12

0 min read     Updated on 10 Jun 2026, 04:49 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Senores Pharmaceuticals announced a virtual investor conference on June 12, 2026, hosted by Choice Broking. The meeting will cover company performance based on public information without sharing UPSI. The schedule is subject to change due to exigencies.

powered bylight_fuzz_icon
42532639

*this image is generated using AI for illustrative purposes only.

Senores Pharmaceuticals has announced a virtual investor conference scheduled for June 12, 2026, to engage with analysts and institutional investors. The meeting aims to discuss the company's performance and outlook based on publicly available information, ensuring no unpublished price sensitive information (UPSI) is shared during the interaction.

The session is scheduled to take place between 03:00 P.M. (IST) and 04:00 P.M. (IST). Choice Broking will host the group meeting, which will be conducted virtually. The company noted that the schedule remains subject to change due to exigencies on the part of the host or the company.

Meeting Details

Date & Time Hosted by Nature of Meeting Mode of Meeting
12 June, 2026
03:00 P.M. (IST) to
04:00 P.M. (IST)
Choice Broking Group Meeting Virtual

The disclosure was made pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Vinay Kumar Mishra, Company Secretary and Compliance Officer, signed the intimation on June 09, 2026.

Historical Stock Returns for Senores Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+11.14%+23.52%+34.68%+68.93%+137.96%+131.58%

What key performance metrics is Senores Pharmaceuticals likely to emphasize during the conference?

How might the investor conference influence market sentiment and stock performance in the short term?

What strategic initiatives or growth drivers could the company outline for the post-2026 period?

Senores Pharmaceuticals
View Company Insights
View All News
like19
dislike

More News on Senores Pharmaceuticals

1 Year Returns:+137.96%